Introduction
People living with ADHD (attention deficit hyperactivity disorder) often require a significant treatment plan to overcome the symptoms. Adderall is a prescription medical stimulant that helps regulate symptoms of ADHD. It includes hyperactivity, impulsivity, inattention, and other specific life activities. However, the ongoing Adderall shortage is concerning for people living with ADHD, which has led to significant distress and disruption in their lives.
In this article, you will learn the cause of the Adderall shortage and potential alternatives to continue their treatment plan.
What Causes the Adderall Shortage?
The ongoing Adderall shortage is a combination of multiple factors that disturb the ADHD treatment of adults and children. It includes disruption in the entire supply chain due to a shortage of active pharmaceutical ingredients (dextroamphetamine and Amphetamine) that delays production. Many companies are facing manufacturing issues due to not meeting the demand of the FDA’s strict regulations and quality control measures.
In addition, awareness of ADHD has primarily increased in recent years, with the surge in demand for Adderall due to its effective response. Also, the growing demand for Adderall in adults for their improved concentration has resulted in a shortage of the drug, which affects people with ADHD who can’t get Adderall on time.
The Impact of the Adderall Shortage on ADHD Patients:
ADHD is a brain disorder that requires a lifetime of medical treatment to overcome the symptoms. A recent survey conducted shows that 2.55 to 4% of adults have ADHD in the USA, which costs over $1000 billion annually. In addition, People without ADHD also use Adderall as an off-label medicine to enhance their focus to overcome workload. As a result, many people have experienced a disturbance in their ADHD treatment due to Adderall shortage. Without access to Adderall for ADHD, individuals can experience elevated signs and symptoms such as impulsivity, inattention, and hyperactivity. The Adderall shortage can also cause anxiety and stress in the patients who rely on Adderall only. Even other medications can be used for ADHD treatment, but they may not be practical or leave unwanted potential side effects.
Managing ADHD during the shortage: Adderall Alternatives
With the ongoing Adderall shortage, People living with ADHD are seeking alternative treatment to overcome the symptoms. No alternative medical stimulant is indeed specifically Adderall, but some options can help resume the treatment plan. It includes Ritalin (short-acting stimulant), Vyanse (Long-acting stimulant) and Concerta. After the Adderall shortage, there are generic forms of stimulants available in pharmacies.
From 2022 to 2024 now, Vyanse comes from 13% to 18% in all ADHD prescription fills, which means it is also an effective stimulant for ADHD symptoms. Furthermore, the FDA is working on covering up the Adderall shortage to minimize patient plan disruptions. People living with ADHD need to consult with healthcare professionals when switching the stimulants.
Staying Updated about the Adderall Shortage
Due to the Adderall shortage, the FDA estimates the chances of a complete supply of a generic form (5mg) will come in June 2024. According to the FDA shortage database, multiple companies are manufacturing Adderall and increasing their production of drugs so that they can be readily available in pharmacies. It is essential to stay updated on the latest developments in stimulants, especially Adderall. To stay updated, must follow the considerations:
- You should check the FDA’s website regularly for updates on the Adderall shortage and other ADHD medication supplies.
- The medication recovery updates are available only on the website of TEVA, a reputable pharmaceutical company.
- It can be challenging to keep track of drug shortage and recovery updates without access to a platform like the American Society of Health-System Pharmacists (ASHP), which provides accurate data concerning drug shortages.
Furthermore, many online pharmacies offer mobile applications that help users stay updated when medication stock is available or to refill. It is essential to follow these considerations to minimize the risk of medication shortage
The Future of ADHD Medication Supply
The ongoing Adderall shortage was highlighted in October 2022, and it is now facing multiple challenges for recovery. People living with ADHD require stable and reliable medication to manage its symptoms. It is significant to address the root cause of ADHD medication unavailability to ensure long-term reliable supply. To address this, pharmaceutical companies should focus on potential solutions, including:
- Technological adaptation for drug sourcing and buying material.
- Pharmaceutical manufacturing companies can increase their production to meet the growing demands.
- Strengthen the supply chain work to minimize the risk of delays.
- Research into new medications to develop ADHD medications.
- Enhance the communication between stakeholders.
There is no doubt that the future of ADHD medication supply depends on exploring new solutions in collaboration with healthcare professionals, manufacturers, and patients to come up with better solutions. Staying updated and supporting the ADHD community is essential to minimize the delays.
Conclusion
Attention deficit hyperactivity disorder requires an effective treatment plan to overcome the symptoms. The ongoing Adderall shortage has presented alarming challenges for patients living with ADHD and also highlighted an effective Adderall alternative medication. It is essential to consult with the healthcare professional to determine the best suitable alternative option in response to your ADHD symptoms. Also, staying informed about the Adderall shortage can help an individual to come up with better options.
Reference list
Becker, Z. (2024). Teva’s Adderall makes it off the FDA shortage list while generic ADHD med supply squeeze persists. [online] Fierce Pharma. Available at: https://www.fiercepharma.com/manufacturing/tevas-adderall-makes-it-fda-shortage-list-while-generic-adhd-med-supply-squeeze [Accessed 18 Jan. 2025].
Siegel, D.M. (2023). Adderall shortage hurt my patient’s job performance. He was told to drink coffee instead. [online] USA TODAY. Available at: https://www.usatoday.com/story/opinion/2023/09/05/adderall-shortage-impact-adhd-patients-fda-alternative-medication/70717576007/.
